908 results on '"Okugawa, Yoshinaga"'
Search Results
402. Increased plasma levels of tissue factor pathway inhibitor-activated factor X complex in patients with disseminated intravascular coagulation
- Author
-
Okugawa, Yoshinaga, primary, Wada, Hideo, additional, Noda, Tomohiro, additional, Sakakura, Miho, additional, Nakasaki, Takahiro, additional, Watanabe, Rika, additional, Deguchi, Hiroshi, additional, Gabazza, Esteban C., additional, Mori, Yoshitaka, additional, Nishikawa, Masakatsu, additional, Deguchi, Katsumi, additional, Nobori, Tsutomu, additional, and Shiku, Hiroshi, additional
- Published
- 2000
- Full Text
- View/download PDF
403. Plasma levels of activated protein C-protein C inhibitor complex in patients with hypercoagulable states
- Author
-
Watanabe, Rika, primary, Wada, Hideo, additional, Sakakura, Miho, additional, Mori, Yoshitaka, additional, Nakasaki, Takahiro, additional, Okugawa, Yoshinaga, additional, Gabazza, Esteban C., additional, Hayashi, Tatsuya, additional, Nishioka, Junji, additional, Suzuki, Koji, additional, Shiku, Hiroshi, additional, and Nobori, Tsutomu, additional
- Published
- 2000
- Full Text
- View/download PDF
404. Single-port laparoscopic management of adhesive small bowel obstruction.
- Author
-
Hiro, Junichiro, Inoue, Yasuhiro, Okugawa, Yoshinaga, Kawamoto, Aya, Okita, Yoshiki, Toiyama, Yuji, Tanaka, Koji, Uchida, Keiichi, Mohri, Yasuhiko, and Kusunoki, Masato
- Subjects
BOWEL obstructions ,LAPAROSCOPIC surgery ,ABDOMINAL surgery ,SURGICAL complications ,TISSUE adhesions ,THERAPEUTICS - Abstract
Laparoscopic adhesiolysis has been the focus of much recent attention; however, the role of single-port laparoscopic surgery for adhesive small bowel obstruction remains unclear. We report our experience of performing single-port laparoscopic surgery for adhesive small bowel obstruction through a retrospective review of 15 consecutive patients who underwent single-port laparoscopic surgery for single adhesive small bowel obstruction between 2010 and 2012. We analyzed data on patient demographics, operating time, conversion, and surgical morbidity. Surgery was completed successfully without conversion to laparotomy or the need for additional intraoperative ports in 14 patients, but the remaining patient had peritoneal dissemination from colon cancer. The median operative time was 49 (25-148) min, and the estimated blood loss was 19 (2-182) ml. There were no major postoperative complications. We conclude that single-port laparoscopic surgery is a technically feasible approach for selected patients with adhesive small bowel obstruction when preoperative imaging identifies a single adhesive obstruction. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
405. Chemoradiotherapy followed by restorative proctocolectomy with partial intersphincteric resection for advanced rectal cancer associated with ulcerative colitis: report of a case.
- Author
-
Inoue, Yasuhiro, Araki, Toshimitsu, Okugawa, Yoshinaga, Kawamoto, Aya, Hiro, Junichiro, Toiyama, Yuji, Tanaka, Koji, Uchida, Keiichi, Mohri, Yasuhiko, and Kusunoki, Masato
- Subjects
SURGICAL anastomosis ,ULCERATIVE colitis ,RECTAL cancer ,RESTORATIVE proctocolectomy ,RECTAL surgery - Abstract
The role of restorative proctocolectomy with ileal J-pouch anal anastomosis (IPAA) is uncertain for patients with ulcerative colitis (UC), when advanced lower rectal cancer is diagnosed. We report what to our knowledge is the first documented case of successful preoperative chemoradiotherapy followed by IPAA with partial intersphincteric resection of advanced rectal cancer associated with UC. A 59-year-old woman with a 24-year history of extensive UC was found to have advanced rectal cancer located 2 cm from the anal verge. She underwent preoperative conventional chemoradiotherapy followed by restorative proctocolectomy with total mesorectal excision. The procedure included intersphincteric resection of one quadrant and construction of an IPAA with diverting ileostomy. The postoperative course was uneventful, and the ileostomy was closed 6 months after the initial surgery. The patient was doing well with good pouch function and no evidence of recurrent disease 1 year after her initial surgery. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
406. Trehalose does not affect the functions of human neutrophils in vitro.
- Author
-
Tanaka, Koji, Kawamura, Mikio, Otake, Kohei, Toiyama, Yuji, Okugawa, Yoshinaga, Inoue, Yasuhiro, Uchida, Keiichi, Araki, Toshimitsu, Mohri, Yasuhiko, and Kusunoki, Masato
- Subjects
TREHALOSE ,NEUTROPHILS ,ESCHERICHIA coli ,STAPHYLOCOCCUS aureus ,LIPOPOLYSACCHARIDES ,INTERLEUKIN-1 - Abstract
Purpose: Trehalose, naturally occurring disaccharide, has been reported to prevent postoperative abdominal adhesions in animal models. We investigated whether trehalose affects the function of human polymorphonuclear neutrophils (PMNs) in vitro to assess the feasibility of its clinical application as an anti-adhesive barrier. Methods: Human PMNs were obtained from 17 healthy volunteers. Escherichia coli and Staphylococcus aureus were used for the bacterial infection model, whereas lipopolysaccharide (LPS) and interleukin (IL)-1β were used for inflammation induction model. The PMN phagocytosis rates of bacteria and apoptosis/necrosis were assessed on trehalose, maltose, and control media. Cytokines; namely, tumor necrosis factor-α, IL-1α, IL-1Ra, IL-6, and IL-8; and PMN-elastase were measured on each medium in both models. Results: There were no significant differences in the phagocytosis rates, apoptosis/necrosis rates, or levels of all cytokines or PMN-elastase among the three media in the bacterial infection model. There were also no significant differences in the levels of all cytokines and PMN-elastase among the three media in the IL-1β inflammation induction model. PMN-elastase was lower in trehalose and maltose medium after LPS stimulation, at 3 and 24 h. Conclusions: Our results suggest that trehalose does not affect the cellular function, cytokine production, or release of PMN-elastase of human PMNs in an in vitro bacterial infection model. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
407. Clinical utility of lymphocyte to C-reactive protein ratio in predicting survival and postoperative complication for esophago-gastric junction cancer
- Author
-
Tsujiura, Masahiro, Yamamoto, Akira, Imaoka, Hiroki, Shimura, Tadanobu, Kitajima, Takahito, Morimoto, Yuhki, Kawamura, Mikio, Yasuda, Hiromi, Okita, Yoshiki, Yokoe, Takeshi, Okugawa, Yoshinaga, Ohi, Masaki, and Toiyama, Yuji
- Abstract
There are still no useful predictive biomarkers for esophago-gastric junction (EGJ) cancer. We compared 15 candidate inflammation-based markers and investigated the clinical impact of the selected biomarker.
- Published
- 2022
- Full Text
- View/download PDF
408. TPX2 is a prognostic marker and promotes cell proliferation in neuroblastoma.
- Author
-
Koike, Yuhki, Yin, Chengzeng, Sato, Yuki, Nagano, Yuka, Yamamoto, Akira, Kitajima, Takahito, Shimura, Tadanobu, Kawamura, Mikio, Matsushita, Kohei, Okugawa, Yoshinaga, Amano, Keishiro, Otake, Kohei, Okita, Yoshiki, Ohi, Masaki, Inoue, Mikihiro, Uchida, Keiichi, Hirayama, Masahiro, and Toiyama, Yuji
- Subjects
PROGNOSIS ,CELL proliferation ,GENE amplification ,NEUROBLASTOMA ,CELL physiology - Abstract
Targeting protein for Xenopus kinesin-like protein 2 (TPX2) is upregulated in various tumors, and several studies have demonstrated the role of TPX2 as a prognostic marker in cancer. However, the function of TPX2 in neuroblastoma (NB) has not been completely elucidated. In the present study, the clinical significance and functional role of TPX2 in NB was investigated. The Therapeutically Applicable Research to Generate Effective Treatments (TARGET)-NB dataset was used. A total of 43 patients with NB were enrolled in the present study as the validation set. After evaluating the prognostic role of TPX2, the combined predictive effect of TPX2 and MYCN proto-oncogene bHLH transcription factor (MYCN) gene amplification was assessed. Double immunofluorescence staining for TPX2 and N-Myc was used to analyze colocalization, and multiple cell function tests were performed by means of in vitro experiments to elucidate the functional role of TPX2 using RNA interference technology in NB cell lines. In both the TARGET-NB set and the validation set, it was found that upregulated of TPX2 was significantly associated with poor overall survival (OS) in patients with NB. The expression of TPX2 was higher in NB patients with MYCN gene amplification, and NB patients with high TPX2 expression and MYCN gene amplification had the poorest OS compared with patients with low TPX2 expression or a single copy of MYCN. In vitro experiments indicated that TPX2 positively regulated cell proliferation and the cell cycle, and promoted cell survival by increasing the resistance to apoptosis. The colocalization of TPX2 with N-Myc in NB cells and tissue was observed. The findings of the present study indicate that TPX2 plays an oncogenic role in NB development and may be a potential prognostic indicator in patients with NB. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
409. Investigation of miRNA expression profiles using cohort samples reveals potential early detectability of colorectal cancers by serum miR-26a-5p before clinical diagnosis.
- Author
-
Hishida, Asahi, Yamada, Hiroya, Ando, Yoshitaka, Okugawa, Yoshinaga, Shiozawa, Manabu, Miyagi, Yohei, Daigo, Yataro, Toiyama, Yuji, Shirai, Yumiko, Tanaka, Koji, Kubo, Yoko, Okada, Rieko, Nagayoshi, Mako, Tamura, Takashi, Mori, Atsuyoshi, Kondo, Takaaki, Hamajima, Nobuyuki, Takeuchi, Kenji, and Wakai, Kenji
- Subjects
COLORECTAL cancer ,MICRORNA ,EARLY detection of cancer - Abstract
Previous studies have investigated the usefulness of microRNA (miRNA/miR) expression data for the early detection of colorectal cancer (CRC). However, limited data are available regarding miRNAs that detect CRC before clinical diagnoses. Accordingly, the present study investigated the early detectability of CRC by miRNAs using the preserved serum samples of the cohort participants affected with CRC within 2 years of study enrollment. First, the significant miRNAs were revealed using clinical CRC samples for a (seven early CRCs and seven controls) microarray analysis based on significance analysis of microarrays. Next, replicability was verified by reverse transcription-quantitative (RT-q)PCR (eight early CRCs and eight controls, together with 12 CRCs and 12 controls). Finally, early detectability was tested using the cohort samples of Japan Multi-Institutional Collaborative Cohort Study (17 CRCs and 17 controls) to reveal how a certain number of patients developed CRC within 2 years after participation. In the discovery phase, miRNA expression measurements were conducted using a 3D-Gene Human miRNA Oligo Chip for 2,555 miRNAs, and RT-qPCR analyses were performed to validate the replicability. In the first validation set with eight CRCs with early clinical stage and eight age- and gender-matched controls, miR-26a-5p and miR-223-3p demonstrated the highest diagnostic accuracy of area under the curve (AUC)=1.000 (sensitivity and specificity 100%). In an examination of the predictability of CRC incidence using pre-clinical cohort samples, miR-26a-5p demonstrated good predictability of advanced CRC incidence with an AUC of 0.840. Overall, the present study revealed serum miR-26a-5p as a potential early detection marker for CRC. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
410. Smad interacting protein 1 (SIP1) is associated with peritoneal carcinomatosis in intestinal type gastric cancer.
- Author
-
Okugawa, Yoshinaga, Inoue, Yasuhiro, Tanaka, Koji, Kawamura, Mikio, Saigusa, Susumu, Toiyama, Yuji, Ohi, Masaki, Uchida, Keiichi, Mohri, Yasuhiko, and Kusunoki, Masato
- Abstract
Smad interacting protein 1 (SIP1) is an epithelial-mesenchymal transition (EMT)-inducible gene that plays a key role in tumor progression in various cancers. This study seeks to clarify the clinical and biological significance of SIP1 expression, especially in intestinal type gastric cancer. We analyzed the mRNA levels of SIP1 and other EMT regulators by real-time reverse transcription PCR in gastric tissue samples of 134 gastric cancer patients, and in five gastric cancer cell lines. SIP1 gene knockdown by siRNA transfection was performed to evaluate SIP1 function in gastric cancer cells. Expression of the SIP1 gene was significantly higher in cancerous tissue than in adjacent normal mucosa. Although the mRNA expression of the other EMT regulators tested (Snail, Slug, and Twist) was not correlated with clinicopathological factors, increased SIP1 expression was an independent prognostic factor and an independent risk factor for peritoneal dissemination. In addition, SIP1 expression was significantly positive and correlated with vimentin expression. For intestinal type gastric cancer in particular, elevated SIP1 expression was significantly correlated with peritoneal dissemination and poor prognosis ( p < 0.05). In vitro, cell proliferation, migration, invasion, and resistance to anoikis were significantly inhibited in SIP1 siRNA-transfected MKN7 cells compared to control siRNA. SIP1 appears to play an important role in progression to peritoneal carcinomatosis and may be a therapeutic target for patients with intestinal type gastric cancer. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
411. Clinical significance of peritumoral mast cells in esophageal squamous cell carcinoma with neoadjuvant chemoradiotherapy.
- Author
-
Saigusa, Susumu, Tanaka, Koji, Ohi, Masaki, Ishino, Yoshito, Yasuda, Hiromi, Okugawa, Yoshinaga, Toiyama, Yuji, Inoue, Yasuhiro, Uchida, Keiichi, Mohri, Yasuhiko, and Kusunoki, Masato
- Abstract
Background: Neoadjuvant chemoradiotherapy (CRT) followed by surgery is the standard approach for locally advanced esophageal cancer. Recently, the microenvironment (including the host immune response) after conventional chemo- and/or radiotherapy has been highlighted. The aim of this preliminary study was to evaluate peritumoral mast cells (MCs) in esophageal squamous cell carcinoma (ESCC) after neoadjuvant CRT. Methods: We obtained a total of twenty specimens from patients with ESCC who underwent neoadjuvant CRT (30-40 Gy; 5-fluorouracil plus cisplatin) followed by surgery. We evaluated the expression of tryptase by MCs, Foxp3 by regulatory T cells, CD8 by cytotoxic T cells, and microvessel density (MVD) using immunohistochemistry. We investigated the correlation between the sizes of these marker-positive cell populations surrounding residual tumor nests, MVD and CRP, and clinical outcome. Results: Patients with a low number of peritumoral MCs more frequently had lymphatic invasion ( P = 0.0191). There was no significant correlation among the sizes of the marker-positive cell populations. We observed a significant negative correlation between the number of MCs and preoperative CRP levels ( P = 0.009). Low numbers of peritumoral MCs, high MVD, and a preoperative C-reactive protein of >0.5 mg/dL were significantly associated with poor overall survival (MCs: P = 0.0239; MVD: P = 0.0317; CRP: P = 0.0395). Conclusion: Our results suggest that peritumoral MCs may be associated with prognosis in patients with ESCC after neoadjuvant CRT. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
412. Significant correlation between LKB1 and LGR5 gene expression and the association with poor recurrence-free survival in rectal cancer after preoperative chemoradiotherapy.
- Author
-
Saigusa, Susumu, Inoue, Yasuhiro, Tanaka, Koji, Toiyama, Yuji, Kawamura, Mikio, Okugawa, Yoshinaga, Okigami, Masato, Hiro, Junichiro, Uchida, Keiichi, Mohri, Yasuhiko, and Kusunoki, Masato
- Published
- 2013
- Full Text
- View/download PDF
413. Prognostic significance of glucose transporter-1 (GLUT1) gene expression in rectal cancer after preoperative chemoradiotherapy.
- Author
-
Saigusa, Susumu, Toiyama, Yuji, Tanaka, Koji, Okugawa, Yoshinaga, Fujikawa, Hiroyuki, Matsushita, Kohei, Uchida, Keiichi, Inoue, Yasuhiro, and Kusunoki, Masato
- Subjects
RECTAL cancer ,CANCER cells ,GLYCOLYSIS ,GLUCOSE transporters ,THERAPEUTICS ,CANCER treatment - Abstract
Purpose: Most cancer cells exhibit increased glycolysis. The elevated glucose transporter 1 (GLUT1) expression has been reported to be associated with resistance to therapeutic agents and a poor prognosis. We wondered whether GLUT1 expression was associated with the clinical outcome in rectal cancer after preoperative chemoradiotherapy (CRT), and whether glycolysis inhibition could represent a novel anticancer treatment. Methods: We obtained total RNA from residual cancer cells using microdissection from a total of 52 rectal cancer specimens from patients who underwent preoperative CRT. We performed transcriptional analyzes, and studied the association of the GLUT1 gene expression levels with the clinical outcomes. In addition, we examined each proliferative response of three selected colorectal cancer cell lines to a glycolysis inhibitor, 3-bromopyruvic acid (3-BrPA), with regard to their expression of the GLUT1 gene. Results: An elevated GLUT1 gene expression was associated with a high postoperative stage, the presence of lymph node metastasis, and distant recurrence. Moreover, elevated GLUT1 gene expression independently predicted both the recurrence-free and overall survival. In the in vitro studies, we observed that 3-BrPA significantly suppressed the proliferation of colon cancer cells with high GLUT1 gene expression, compared with those with low expression. Conclusion: An elevated GLUT1 expression may be a useful predictor of distant recurrence and poor prognosis in rectal cancer patients after preoperative CRT. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
414. Intravital dual-colored visualization of colorectal liver metastasis in living mice using two photon laser scanning microscopy.
- Author
-
Tanaka, Koji, Morimoto, Yuhki, Toiyama, Yuji, Okugawa, Yoshinaga, Inoue, Yasuhiro, Uchida, Keiichi, Kimura, Kazushi, Mizoguchi, Akira, and Kusunoki, Masato
- Abstract
A major challenge of cancer biology is to visualize the dynamics of the metastatic process in secondary organs at high optical resolution in vivo real-time. Here, we presented intravital, dual-colored imaging of liver metastasis formation from a single cancer cell to metastatic colonies in the living liver of living mice using two photon laser scanning microscopy (TPLSM). Red fluorescent protein expressing murine (SL4) or human (HT29) colorectal cancer cell lines were inoculated to the spleen of green fluorescent protein expressing mice. Intravital TPLSM was performed by exteriorizing and fixing the liver lobe of living mice. This was repeated several times for the long-term imaging of the same mouse. Viable cancer cells in the living liver of living mice were visualized intravitally at a magnification of over 600×. Single cancer cells were arrested within hepatic sinusoids 2 h after injection. Platelet aggregation surrounding a cancer cell was observed, indicating a phenomenon of tumor-cell induced platelet aggregation. Cancer cells were extravasated from hepatic sinusoids to the space of Disse. Protrusions of Kupffer cells surrounding a cancer cell were observed, indicating that Kupffer cells appear to phagocytose cancer cells. SL4 cells formed liver metastatic colonies with extensive stromal reaction. Liver metastases by HT29 cells were observed as a cluster of micrometastatic nodules. High-resolution, dual-colored, real-time visualization of cancer metastasis using intravital TLPSM can help to understand spatiotemporal tumor-host interactions during metastatic processes in the living organs of living animals. Microsc. Res. Tech. 2011. © 2011 Wiley Periodicals, Inc. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
415. Coagulation Tests and Anti-Phospholipid Antibodies in Patients Positive for Lupus Anticoagulant.
- Author
-
Sakakura, Miho, Wada, Hideo, Watanabe, Rika, Mamamuro, Miho, Okugawa, Yoshinaga, Nakasaki, Takahiro, Nakase, Tutomu, Wakita, Yoshihiro, Minamikawa, Kouzou, Mori, Yositaka, Nshikawa, Masakatsu, and Shiku, Hiroshi
- Subjects
BLOOD coagulation tests ,PHOSPHOLIPID antibodies ,PATIENTS ,BLOOD coagulation disorders ,ANTICOAGULANTS - Abstract
We examined activated partial thromboplastin lime, kaolin clotting time, mixing with normal plasma in kaolin clotting time, dilute Russell's viper venom lime, dilute Russell's viper venom time at high lipid concentrations, anti-phospholipid antibodies, and anti-cardiolipin-β2-glycoprotein 1 complex antibody in 135 patients with prolongation of activated partial thromboplastin time and diagnosed 86 patients positive for lupus anticoagulant. The sensitivity of activated partial thromboplastin time and dilute Russell's viper venom time/dilute Russell's viper venom time-high lipid concentrations ratio for lupus anticoagulant were markedly high, but the specificity of activated partial thromboplastin time for lupus anticoagulant was not markedly high. The specificity, but not the sensitivity, of kaolin clotting time-mixing with normal plasma in kaolin clotting time was markedly high. In summary, dilute Russell's viper venom time to dilute Russell's viper venom time-high lipid concentrations ratio gave high sensitivity as well as specificity, being the only assay to confirm this. Of the patients positive fur lupus anticoagulant. 25% were positive for anti-phospholipid antibodies and 17% were positive for anti-cardiolipin-β2-glycoprotein I complex antibody. Of the lupus anticoagulant-positive patients with thrombosis. 45% were positive for anti-phospholipid antibodies. 35% were positive for anti-cardiolipin-β2-glycoprotein 1 complex antibody. 60% were positive for both anti-phospholipid antibodies and anti-cardiolipin-β2-glycoprotein I complex antibody, and only 17% were negative for anti-phospholipid antibodies and anti-cardiolipin-β2-glycoprotein I complex antibody. These findings suggest that lupus anticoagulant can be diagnosed by dilute Russell's viper venom time/dilute Russell's viper venom time-high lipid concentrations ratio, and that thrombosis in lupus anticoagulant-positive may be predictable from both anti-phospholipid antibodies... [ABSTRACT FROM AUTHOR]
- Published
- 2000
- Full Text
- View/download PDF
416. MO1-1 Lymphocyte-C-reactive protein ratio as a prognostic marker in rectal cancer patients with neoadjuvant chemoradiotherapy.
- Author
-
Okugawa, Yoshinaga, Fujikawa, Hiroyuki, Omura, Yusuke, Yamamoto, Akira, Kitajima, Takahito, Shimura, Tadanobu, Imaoka, Hiroki, Kawamura, Mikio, Yasuda, Hiromi, Okita, Yoshiki, Yokoe, Takeshi, Saigusa, Susumu, Mochiki, Ikuyo, Ohi, Masaki, Nakatani, Kaname, and Toiyama, Yuji
- Subjects
- *
RECTAL cancer treatment , *C-reactive protein , *CHEMORADIOTHERAPY - Published
- 2021
- Full Text
- View/download PDF
417. Antitumor effects of Andrographis via ferroptosis-associated genes in gastric cancer.
- Author
-
Ma, Ruiya, Shimura, Tadanobu, Yin, Chengzeng, Okugawa, Yoshinaga, Kitajima, Takahito, Koike, Yuhki, Okita, Yoshiki, Ohi, Masaki, Uchida, Keiichi, Goel, Ajay, Yao, Li, Zhang, Xueming, and Toiyama, Yuji
- Subjects
CANCER genes ,STOMACH cancer ,PROGNOSIS ,CELL lines ,CELL proliferation ,CELL death - Abstract
The overall prognosis of advanced/metastatic gastric cancer (GC) remains poor despite the development of pharmacotherapy. Therefore, other treatment options, such as complementary and alternative medicine, should be considered to overcome this aggressive malignancy. Andrographis, which is a generally unharmful botanical compound, has gained increasing interest for its anticancer effects in multiple malignancies via the regulation of cancer progression-associated signaling pathways. In the present study, a series of in vitro experiments (cell proliferation, colony formation and apoptosis assays) was designed to elucidate the antitumor potential and mechanism of Andrographis in GC cells. The present study demonstrated that Andrographis exerted antitumor effects in GC cell lines (MKN74 and NUGC4) by inhibiting proliferation, reducing colony formation and enhancing apoptotic activity. Furthermore, it was demonstrated that the expression levels of the ferroptosis-associated genes heme oxygenase-1, glutamate-cysteine ligase catalytic and glutamate-cysteine ligase modifier were significantly upregulated after Andrographis treatment in both GC cell lines in reverse transcription-quantitative PCR experiments (P<0.05); this finding was further confirmed by immunoblotting assays (P<0.05). In conclusion, to the best of our knowledge, the present study was the first to demonstrate that Andrographis possessed antitumor properties by altering the expression levels of ferroptosis-associated genes, thereby providing novel insights into the potential of Andrographis as an adjunctive treatment option for patients with metastatic GC. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
418. 320 CUMURATIVE PERIOPERTIVE LYMPHOCYTE/C-REACTIVE PROTEIN RATIO AS A PREDICTOR OF LONG-TERM OUTCOMES IN PATIENTS WITH COLORECTAL CANCER.
- Author
-
Okugawa, Yoshinaga, Fujikawa, Hiroyuki, Omura, Yusuke, Yamamoto, Akira, Kitajima, Takahito, Shimura, Tadanobu, Imaoka, Hiroki, Yasuda, Hiromi, Okita, Yoshiki, Yokoe, Takeshi, Mochiki, Ikuyo, Ohi, Masaki, Nakatani, Kaname, and Toiyama, Yuji
- Published
- 2021
- Full Text
- View/download PDF
419. Fusobacterium nucleatum infection correlates with two types of microsatellite alterations in colorectal cancer and triggers DNA damage.
- Author
-
Okita, Yoshiki, Koi, Minoru, Takeda, Koki, Ross, Ryan, Mukherjee, Bhramar, Koeppe, Erika, Stoffel, Elena M., Galanko, Joseph A., McCoy, Amber N., Keku, Temitope O., Okugawa, Yoshinaga, Kitajima, Takahito, Toiyama, Yuji, Martens, Eric, and Carethers, John M.
- Subjects
DOUBLE-strand DNA breaks ,COLORECTAL cancer ,DNA damage ,MICROSATELLITE repeats ,FUSOBACTERIUM ,P16 gene - Abstract
Fusobacterium nucleatum (Fn) is frequently found in colorectal cancers (CRCs). High loads of Fn DNA are detected in CRC tissues with microsatellite instability-high (MSI-H), or with the CpG island hypermethylation phenotype (CIMP). Fn infection is also associated with the inflammatory tumor microenvironment of CRC. A subtype of CRC exhibits inflammation-associated microsatellite alterations (IAMA), which are characterized by microsatellite instability-low (MSI-L) and/or an elevated level of microsatellite alterations at selected tetra-nucleotide repeats (EMAST). Here we describe two independent CRC cohorts in which heavy or moderate loads of Fn DNA are associated with MSI-H and L/E CRC respectively. We also show evidence that Fn produces factors that induce γ-H2AX, a hallmark of DNA double strand breaks (DSBs), in the infected cells. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
420. Novel mutation of transferrin receptor 2 causing hereditary hemochromatosis type 3 in a Japanese patient.
- Author
-
Tamai, Yasuyuki, Hosotani, Masami, Shigefuku, Ryuta, Tsuboi, Junya, Iwasa, Motoh, Okugawa, Yoshinaga, and Nakagawa, Hayato
- Abstract
Hereditary hemochromatosis (HH) is recognized as a progressive iron‐storage disorder, and leading to severe organ impairments, including liver cirrhosis. Hereditary hemochromatosis type 3 arises from mutations in the transferrin receptor 2 (
TFR2 ) gene. However, HH type 3 is rare in Asia, and information regarding genetic mutations and associated phenotypes remains limited. Here, we reported the case of a Japanese patient with HH type 3, with a novel homozygous mutation of theTFR2 gene. A 69‐year‐old woman presented to our hospital with hand joint pain and was referred due to liver impairment. Viral hepatitis and autoimmune liver diseases were ruled out. However, the transferrin saturation was 92.2%, and the serum ferritin level was 1611.8 ng/mL. Additionally, abdominal computed tomography showed diffuse increased density of the liver parenchyma. Abdominal magnetic resonance imaging also suggested iron deposition. There is no history of prior treatments involving blood transfusions or iron agents. Her parents were involved in a consanguineous marriage, prompting genetic testing. She had a homozygous novel mutation, c.1337G>A (p.G446E), in theTFR2 gene. Serum hepcidin‐25 level was decreased to 2.9 ng/mL. According to the American Society of Medical Genetics and Genomics guideline, the mutation was classified as likely pathogenic, leading to the diagnosis of HH type 3. Following phlebotomy, her arthritis resolved, and serum transaminase levels were normalized. This case marks the first demonstration of homozygous mutation, c.1337G>A (p.G446E), in theTFR2 gene in patients with HH type 3. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
421. Enhanced AZIN1 RNA editing and overexpression of its regulatory enzyme ADAR1 are important prognostic biomarkers in gastric cancer.
- Author
-
Okugawa, Yoshinaga, Toiyama, Yuji, Shigeyasu, Kunitoshi, Yamamoto, Akira, Shigemori, Tsunehiko, Yin, Chengzeng, Ichikawa, Takashi, Yasuda, Hiromi, Fujikawa, Hiroyuki, Yoshiyama, Shigeyuki, Hiro, Junichiro, Ohi, Masaki, Araki, Toshimitsu, Kusunoki, Masato, and Goel, Ajay
- Subjects
- *
RNA editing , *GENE expression , *STOMACH cancer , *POLYMERASE chain reaction , *BIOMARKERS , *CANCER prognosis - Abstract
Background: Adenosine-to-inosine (A-to-I) RNA editing is catalyzed by adenosine deaminases acting on RNA (ADAR) enzymes. Recent evidence suggests that RNA editing of antizyme inhibitor 1 (AZIN1) RNA is emerging as a key epigenetic alteration underlying cancer pathogenesis.Methods: We evaluated AZIN1 RNA editing levels, and the expression of its regulator, ADAR1, in 280 gastric tissues from 140 patients, using a RNA editing site-specific quantitative polymerase chain reaction assays. We also analyzed the clinical significance of these results as disease biomarkers in gastric cancer (GC) patients.Results: Both AZIN1 RNA editing levels and ADAR1 expression were significantly elevated in GC tissues compared with matched normal mucosa (P < 0.0001, 0.0008, respectively); and AZIN1 RNA editing was positively correlated with ADAR1 expression. Elevated expression of ADAR1 significantly correlated with poor overall survival (P = 0.034), while hyper-edited AZIN1 emerged as an independent prognostic factor for OS and disease-free survival in GC patients [odds ratio (OR):1.98, 95% CI 1.17-3.35, P = 0.011, OR: 4.55, 95% CI 2.12-9.78, P = 0.0001, respectively]. Increased AZIN1 RNA editing and ADAR1 over-expression were significantly correlated with key clinicopathological factors, such as advanced T stage, presence of lymph node metastasis, distant metastasis, and higher TNM stages in GC patients. Logistic regression analysis revealed that hyper-editing status of AZIN1 RNA was an independent risk factor for lymph node metastasis in GC patients [hazard ratio (HR):3.03, 95% CI 1.19-7.71, P = 0.02].Conclusions: AZIN1 RNA editing levels may be an important prognostic biomarker in GC patients, and may serve as a key clinical decision-making tool for determining preoperative treatment strategies in GC patients. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
422. N-BLR, a primate-specific non-coding transcript leads to colorectal cancer invasion and migration
- Author
-
Shah, Maitri Y., Lopez-Berestein, Gabriel, Liu, Chang Gong, Nam, Su Youn, Jing, Yi, Esteller, Manel, Ling, Hui, Yeh, Jen Jen, Gafà, Roberta, Ferdin, Jana, Rodriguez-Aguayo, Cristian, Pichler, Martin, Negrini, Massimo, Spizzo, Riccardo, Ivan, Cristina, Zhang, Xinna, Nicoloso, Milena S., Calin, George A., Telonis, Aristeidis G., Menter, David, Melo, Sonia A., Lanza, Giovanni, Tsirigos, Aristotelis, Kopetz, Scott, Rigoutsos, Isidore, Bar-Eli, Menashe, Clark, Peter M., Okugawa, Yoshinaga, Tiron, Aida, Catela Ivkovic, Tina, Jung, Eun Jung, Flores, Elsa R., Huang, Li, Mani, Sendurai A., Pasculli, Barbara, Paranjape, Anurag N., Anfossi, Simone, Lee, Sang Kil, Xiao, Lianchun, Shimizu, Masayoshi, Berindan-Neagoe, Ioana, Redis, Roxana S., Rossi, Simona, Goel, Ajay, Fabris, Linda, Shariati, Maryam, Jiang, Zhi-Qin, and Teruel-Montoya, Raul
- Subjects
3. Good health - Abstract
Background Non-coding RNAs have been drawing increasing attention in recent years as functional data suggest that they play important roles in key cellular processes. N-BLR is a primate-specific long non-coding RNA that modulates the epithelial-to-mesenchymal transition, facilitates cell migration, and increases colorectal cancer invasion. Results We performed multivariate analyses of data from two independent cohorts of colorectal cancer patients and show that the abundance of N-BLR is associated with tumor stage, invasion potential, and overall patient survival. Through in vitro and in vivo experiments we found that N-BLR facilitates migration primarily via crosstalk with E-cadherin and ZEB1. We showed that this crosstalk is mediated by a pyknon, a short ~20 nucleotide-long DNA motif contained in the N-BLR transcript and is targeted by members of the miR-200 family. In light of these findings, we used a microarray to investigate the expression patterns of other pyknon-containing genomic loci. We found multiple such loci that are differentially transcribed between healthy and diseased tissues in colorectal cancer and chronic lymphocytic leukemia. Moreover, we identified several new loci whose expression correlates with the colorectal cancer patients’ overall survival. Conclusions The primate-specific N-BLR is a novel molecular contributor to the complex mechanisms that underlie metastasis in colorectal cancer and a potential novel biomarker for this disease. The presence of a functional pyknon within N-BLR and the related finding that many more pyknon-containing genomic loci in the human genome exhibit tissue-specific and disease-specific expression suggests the possibility of an alternative class of biomarkers and therapeutic targets that are primate-specific.
423. Clinical implications of the preoperative lymphocyte C-reactive protein ratio in esophageal cancer patients.
- Author
-
Yamamoto, Akira, Toiyama, Yuji, Okugawa, Yoshinaga, Ichikawa, Takashi, Imaoka, Hiroki, Yasuda, Hiromi, Fujikawa, Hiroyuki, Okita, Yoshiki, Yokoe, Takeshi, and Ohi, Masaki
- Subjects
- *
C-reactive protein , *CANCER patients , *SURGICAL site infections , *PROGRESSION-free survival , *PROGNOSIS , *ESOPHAGEAL cancer - Abstract
Purpose: We recently revealed the preoperative lymphocyte C-reactive protein ratio (LCR) to be a new marker for predicting various outcomes in malignancies. The aim of our present study was to clarify the potential utility of the preoperative LCR for predicting the perioperative risk and oncological outcome in esophageal cancer patients. Methods: We analyzed the preoperative LCR from 153 esophageal cancer patients to clarify its clinical relevance. Results: The preoperative LCR was significantly decreased in a stage-dependent manner, and a decreased preoperative LCR was significantly associated with the occurrence of postoperative surgical site infection. Esophageal cancer patients with a low LCR showed a poor outcome in both the overall survival and disease-free survival compared with those who had a high LCR. Multivariate analyses showed that a decreased LCR was an independent prognostic factor for both a poor overall survival and disease-free survival. A decreased preoperative LCR was an independent predictive factor for postoperative surgical site infection and significantly correlated with nutritional and inflammatory indicators. In addition, the LCR was useful for identifying esophageal cancer patients likely to have a poor outcome among patients with and without neoadjuvant chemotherapy. Conclusions: Assessing the preoperative LCR might help physicians identify populations at high risk for perioperative complication and oncological outcomes, and determine individualized perioperative therapeutic strategies. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
424. Promoter methylation levels of microRNA-124 in non-neoplastic rectal mucosa as a potential biomarker for ulcerative colitis-associated colorectal cancer in pediatric-onset patients.
- Author
-
Koike, Yuhki, Yin, Chengzeng, Sato, Yuki, Nagano, Yuka, Yamamoto, Akira, Kitajima, Takahito, Shimura, Tadanobu, Kawamura, Mikio, Matsushita, Kohei, Okugawa, Yoshinaga, Amano, Keishiro, Okita, Yoshiki, Ohi, Masaki, Inoue, Mikihiro, Uchida, Keiichi, Hirayama, Masahiro, and Toiyama, Yuji
- Subjects
- *
COLORECTAL cancer , *METHYLATION , *CANCER patients , *MUCOUS membranes , *RECTAL cancer , *RECEIVER operating characteristic curves - Abstract
Purpose: To determine the methylation level of the miR-124 promoter in non-neoplastic rectal mucosa of patients with pediatric-onset ulcerative colitis (UC) to predict UC-associated colorectal cancer (UC-CRC). Methods: Between 2005 and 2017, non-neoplastic rectal tissue specimens were collected from 86 patients with UC, including 13 patients with UC-CRC; cancer tissues were obtained from the latter group. The methylation status of the miR-124 promoter was quantified using bisulfite pyrosequencing and compared between pediatric- and adult-onset UC patients. Results: Patients with pediatric-onset UC experienced a significantly shorter disease duration than those with adult-onset UC. The levels of miR-124 promoter methylation in non-neoplastic rectal mucosa were positively correlated with the age at the diagnosis and duration of UC. The rate of increase in miR-124 methylation was accelerated in patients with pediatric-onset UC compared to those with adult-onset UC. Furthermore, the miR-124 methylation levels in non-neoplastic rectal mucosa were significantly higher in patients with UC-CRC than in those with UC alone (P = 0.02). A receiver operating characteristic analysis revealed that miR-124 methylation in non-neoplastic tissue discriminated between patients with pediatric-onset UC with or without CRC. Conclusion: miR-124 methylation in non-neoplastic rectal mucosa may be a useful biomarker for identifying patients with pediatric-onset UC who face the highest risk of developing UC-CRC. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
425. High platelet × C-reactive protein level multiplier is a negative prognostic marker in rectal cancer treated by neoadjuvant chemoradiotherapy.
- Author
-
Ide, Shozo, Toiyama, Yuji, Okugawa, Yoshinaga, Shimura, Tadanobu, Fujikawa, Hiroyuki, Hiro, Junichiro, Ohi, Masaki, and Kusunoki, Masato
- Subjects
- *
RECTAL cancer , *C-reactive protein , *CARCINOEMBRYONIC antigen , *CHEMORADIOTHERAPY , *PROPORTIONAL hazards models , *PROGNOSIS , *TUMOR markers - Abstract
Purpose: The clinical significance of the platelet count × C-reactive protein level multiplier (P-CRP) in patients with locally advanced rectal cancer (LARC) undergoing neoadjuvant chemoradiotherapy followed by curative surgery has not been fully evaluated. Methods: In this retrospective study, the correlation between the P-CRP and prognosis was evaluated in 135 patients with LARC. We also performed a subgroup analysis limited to patients with pathological TNM stage III [ypN(+)] LARC. Results: The cut-off value of the P-CRP for prognosis was set at 4.11. The high and low P-CRP groups comprised 39 (28.89%) and 96 (71.11%) patients, respectively. Among the investigated clinicopathological factors, the serum carcinoembryonic antigen level and presence of recurrence were significantly associated with the P-CRP value. In the Kaplan–Meier analysis, both overall survival (OS) and disease-free survival (DFS) were shorter in the high P-CRP group (p < 0.0001 and p = 0.0002, respectively; log-rank test). Multivariate analysis using a Cox proportional hazards model showed that a high P-CRP was an independent prognostic factor for OS [hazard ratio (HR) 29.20; 95% confidence interval (CI), 3.42–294.44; p = 0.0024] and DFS (HR 5.89; 95%CI 1.31–22.69; p = 0.023) in patients with LARC. In addition, a high P-CRP predicted poor OS and DFS in patients with pathological TNM stage III [ypN(+)] LARC (p = 0.0001 and p = 0.0012, respectively; log-rank test). Conclusions: The P-CRP is a promising predictor of survival and recurrence in patients with LARC treated by neoadjuvant chemoradiotherapy followed by curative surgery. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
426. Re: Cumulative burden of inflammation predicts colorectal neoplasia risk in ulcerative colitis: a large single-centre study
- Author
-
Okugawa, Yoshinaga, Toiyama, Yuji, Kusunoki, Masato, and Goel, Ajay
- Published
- 2019
- Full Text
- View/download PDF
427. Prognostic impacts of tumoral expression and serum levels of PD-L1 and CTLA-4 in colorectal cancer patients.
- Author
-
Omura, Yusuke, Toiyama, Yuji, Okugawa, Yoshinaga, Yin, Chengzeng, Shigemori, Tsunehiko, Kusunoki, Kurando, Kusunoki, Yukina, Ide, Shozo, Shimura, Tadanobu, Fujikawa, Hiroyuki, Yasuda, Hiromi, Hiro, Junichiro, Ohi, Masaki, and Kusunoki, Masato
- Subjects
- *
PROGRAMMED death-ligand 1 , *COLORECTAL cancer , *CYTOTOXIC T lymphocyte-associated molecule-4 , *CANCER patients , *APOPTOSIS - Abstract
Background: Programmed cell death ligand-1 (PD-L1) and cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) play a pivotal role in cancer immunotherapy. Each of these molecules has a membrane-bound receptor form (mPD-L1/mCTLA-4) and a soluble form (sPD-L1/sCTLA-4). However, these prognostic impacts in colorectal cancer (CRC) remain unclear. Methods: We immunohistochemically scored tumoral mPD-L1/mCTLA-4 expression and quantified preoperative circulating sPD-L1/sCTLA-4 levels using matched serum specimens from 131 patients with pStage I–III CRC. We also examined the association between these statuses and tumor infiltrating lymphocytes (TILs) in these patients. Results: Elevated levels of mPD-L1, mCTLA-4, sPD-L1 and sCTLA-4 were significantly correlated with poor overall survival (OS) and disease-free survival (DFS). Co-high expression of tumoral mPD-L1 and mCTLA-4 or co-elevated levels of serum sPD-L1 and sCTLA-4 were strongly correlated with poor OS and DFS. Multivariate analysis revealed that both statuses were negative independent prognostic factors for OS [hazard ratio (HR) 3.86, 95% confidence interval (95% CI) 1.71–8.51, p = 0.001; HR 5.72, 95% CI 1.87–14.54, p = 0.004, respectively] and DFS (HR 2.53, 95% CI 1.23–4.95, p = 0.01; HR 6.88, 95% CI 2.42–17.13, p = 0.0008, respectively). Although low expression of tumoral mCTLA-4 was significantly correlated with increased CD8(+) TILs, there was no correlation in any other combination. Conclusions: We verified the prognostic impacts of mPD-L1, mCTLA-4, sPD-L1 and sCTLA-4 in pStage I–III CRC patients. Dual evaluation of immune checkpoint molecules in primary tissues or preoperative serum could identify a patient population with poor prognosis in these patients. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
428. Clinical significance of an increased red blood cell distribution width in patients with rectal cancer undergoing chemoradiotherapy followed by surgery.
- Author
-
Ide, Shozo, Toiyama, Yuji, Okugawa, Yoshinaga, Omura, Yusuke, Kitajima, Takahito, Fujikawa, Hiroyuki, Hiro, Junichiro, Ohi, Masaki, and Kusunoki, Masato
- Subjects
- *
ERYTHROCYTES , *CHEMORADIOTHERAPY , *RECTAL cancer , *CANCER patients , *PROGRESSION-free survival , *SERUM albumin - Abstract
Purpose: The clinical significance of the red blood cell distribution width (RDW) in patients with rectal cancer undergoing preoperative chemoradiotherapy (CRT) followed by surgery has not been fully evaluated. Methods: In this retrospective study, we investigated the association between the RDW and the prognosis in 120 patients with locally advanced rectal cancer (LARC). We also performed a subgroup analysis limited to patients with pathological TNM stage I–II (ypN[−]) LARC. Results: The RDW standard deviation was used to evaluate the RDW. We set 47.1% as the cut-off value of the RDW for the assessment of the prognosis. The RDW exhibited a significant negative relationship with the serum hemoglobin and albumin levels. An elevated RDW was an independent prognostic factor for the overall survival (OS) and disease-free survival (DFS) in patients with LARC. In addition, an elevated RDW predicted a poor OS and DFS in patients with pathological TNM stage I–II (ypN[−]) LARC. Conclusions: The RDW is a promising predictor of a poor survival and recurrence in patients with LARC treated by CRT. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
429. Successful management following combined thoracic endovascular aortic repair and minimally invasive esophagectomy for primary aortoesophageal fistula: A case report.
- Author
-
Yokoe, Takeshi, Toiyama, Yuji, Ichikawa, Takashi, Uratani, Ryo, Imaoka, Hiroki, Yasuda, Hiromi, Morimoto, Yuki, Fujikawa, Hiroyuki, Okugawa, Yoshinaga, Okita, Yoshiki, Yoshiyama, Shigeyuki, and Ohi, Masaki
- Subjects
- *
ENDOVASCULAR aneurysm repair , *MINIMALLY invasive procedures , *FISTULA , *VIDEO-assisted thoracic surgery , *ESOPHAGECTOMY , *AORTIC aneurysms - Abstract
Aortoesophageal fistula (AEF) is a rare but life‐threatening pathology. We report a case of a primary AEF that was successfully managed with temporary thoracic endovascular aortic repair (TEVAR) and esophagectomy with video‐assisted thoracoscopic surgery. A 73‐year‐old man was transferred to the emergency department with a complaint of hematemesis. A computed tomography scan identified an AEF due to aortic aneurysm. We placed a stent using TEVAR for the purpose of hemodynamic stasis, and the operation was performed 23 h after admission. Right video‐assisted thoracoscopic esophagectomy (VATS‐E) was chosen, and a cervical esophagostomy and a feeding gastrostomy tube was constructed. Infection had been effectively controlled postoperatively. Four months after the first operation, we performed esophageal reconstruction. At the 70‐month follow‐up examination, the patient had no signs of mediastinitis. VATS‐E immediately after hemostabilization by TEVAR is useful management for primary AEF. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
430. Next‐generation sequencing clarified why first‐line treatment with osimertinib was ineffective in an autopsied case of EGFR‐mutated lung squamous cell carcinoma.
- Author
-
Nishimura, Tadashi, Fujiwara, Takumi, Fujimoto, Hajime, Tarumi, Hirotoshi, Tsuji, Chikashi, Iwanaka, Soichi, Sakakura, Yasumasa, Naito, Masahiro, Okugawa, Yoshinaga, Yasuma, Taro, Gabazza, Esteban Cesar, Oomoto, Yasuhiro, Kobayashi, Tetsu, and Ibata, Hidenori
- Subjects
- *
DRUG efficacy , *SEQUENCE analysis , *GENETIC mutation , *STAINS & staining (Microscopy) , *AUTOPSY , *EPIDERMAL growth factor receptors , *IMMUNOHISTOCHEMISTRY , *LUNG tumors , *PROTEIN-tyrosine kinase inhibitors , *COMPUTED tomography , *SQUAMOUS cell carcinoma , *DRUG resistance in cancer cells , *BRONCHOSCOPY - Abstract
Epidermal growth factor receptor (EGFR)‐mutated squamous cell carcinoma (SCC) is less common than adenocarcinoma. The third‐generation EGFR‐tyrosine kinase inhibitor, osimertinib, is effective in EGFR‐mutated lung adenocarcinoma, but its efficacy in EGFR‐mutated lung SCC is unclear. The patient was an 83‐year‐old male. He was diagnosed with SCC of the lung, and molecular analysis revealed that the tumor was positive for EGFR exon19 deletion. He was treated with osimertinib 80 mg/day. No adverse events were observed, but after 18 days of therapy, he complained of dyspnea, and a computed tomography scan showed enlarged lung cancer. The case was categorized as a progressive disease. The patient died 3 weeks later. The autopsy findings confirmed the diagnosis of lung SCC, with morphology and immunohistochemical staining identical to the tumor obtained by bronchoscopy. Next‐generation sequencing showed the presence of TP53 R158L, CDK6, and KRAS amplifications. The current case report shows that next‐generation sequencing can explain why osimertinib is ineffective in EGFR‐mutated SCC. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
431. The effect of preoperative rehabilitation on the prevention of postoperative ileus in colorectal cancer patients.
- Author
-
Ushida, Kenta, Yamamoto, Yoshinori, Hori, Shinsuke, Shimizu, Miho, Kato, Yuki, Toiyama, Yuji, Okugawa, Yoshinaga, Shimizu, Akio, and Momosaki, Ryo
- Abstract
Purpose: Previous research suggests that the preoperative rehabilitation of colorectal cancer patients can reduce postoperative ileus. However, the evidence is insufficient and further research is warranted. This study aimed to investigate whether short-term preoperative rehabilitation, both on an outpatient and inpatient basis, can reduce the incidence of postoperative ileus after colorectal cancer surgery. Methods: This was a retrospective cohort study that drew on data from multicenter electronic medical records. Patients with stage 1–3 colorectal cancer who underwent surgery and postoperative rehabilitation were included. The incidence of postoperative ileus was compared between patients who received short-term preoperative rehabilitation and those who did not. Propensity score adjustment using inverse probability weighting and subgroup analysis by type of surgery was performed. Results: Four thousand seventy-six eligible patients (43.4% female; mean age 75.1 ± 10.9 years) were included; 1914 (47.0%) received short-term preoperative rehabilitation. The preoperative rehabilitation group had a significantly lower incidence of postoperative ileus than the no preoperative rehabilitation group (pre-adjustment: 5.5% vs. 9.9%, p < 0.001; post-adjustment: 5.2% vs. 9.0%, p < 0.001). Therefore, preoperative rehabilitation was significantly associated with a lower incidence of postoperative ileus (OR: 0.554, 95% CI: 0.415–0.739, p < 0.001). In an adjusted analysis of surgery type subgroups, the incidence of postoperative ileus was significantly lower in the preoperative rehabilitation group for all types of surgery. Conclusion: Our study showed that short-term preoperative rehabilitation for patients with stage 1–3 colorectal cancer, both with inpatients and outpatients, significantly reduces the incidence of postoperative ileus. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
432. A metastasis‐associated microRNA‐based liquid biopsy signature for risk‐stratification in colorectal cancer: a multicenter cohort study.
- Author
-
Matsuyama, Takatoshi, Toiyama, Yuji, Ishikawa, Toshiaki, Okugawa, Yoshinaga, Yasuno, Masamichi, Maurel, Joan, Kinugasa, Yusuke, Uetake, Hiroyuki, and Goel, Ajay
- Subjects
- *
PROPORTIONAL hazards models , *CETUXIMAB , *COLORECTAL cancer , *REVERSE transcriptase polymerase chain reaction - Abstract
Abbreviations AUC area under the curve CI confidence interval CRC colorectal cancer DFS disease-free survival HR hazard ratio miRNA microRNA ROC receiver operating characteristic Dear Editor, Colorectal cancer (CRC) continuously sheds various subcellular components into the bloodstream, including microRNAs (miRNAs).[[1], [3]] In the current study, we systematically and comprehensively profiled miRNAs in patients with CRC to test the hypothesis that miRNAs highly expressed in metastases are shed into the bloodstream and can act as promising blood-based biomarkers to aid in clinical decision-making, which led us to identify clinically translatable circulating miRNAs for recurrence prediction in patients with stage II and III CRC. Therefore, in the in silico miRNA discovery phase of this study, we aimed to identify candidate miRNAs that were upregulated in liver metastasis compared to normal colon mucosa and surrounding normal liver, ensuring that we can successfully develop clinically actionable circulating metastasis-associated miRNAs. In addition, we evaluated this DFS prediction model in patients with stage II and III CRC separately, demonstrating that high scores were associated with lower DFS rates for patients in both groups ( I P i < .001 for both; Figure 3C,D). [Extracted from the article]
- Published
- 2022
- Full Text
- View/download PDF
433. A blood-based transcriptomic signature for noninvasive diagnosis of gastric cancer.
- Author
-
Lee, In-Seob, Ahn, Jiyoung, Kim, Kwangsoo, Okugawa, Yoshinaga, Toiyama, Yuji, Hur, Hoon, and Goel, Ajay
- Subjects
- *
STOMACH tumors , *RESEARCH , *RESEARCH methodology , *EARLY detection of cancer , *CASE-control method , *PROGNOSIS , *MEDICAL cooperation , *EVALUATION research , *COMPARATIVE studies , *GENE expression profiling , *GENES , *MOLECULAR structure - Abstract
Background: Delayed detection of tumours contributes to poor prognosis in patients with gastric cancer (GC). The invasive nature of endoscopy and the absence of an effective serum markers highlight the need to develop novel, noninvasive biomarkers.Methods: We performed biomarker discovery and validation to identify candidate genes in three gene expression data sets. After validating the gene panel in clinical tissues, we translated the gene panel into serum samples by performing training and validation in 89 samples from GC patients and 54 from healthy donors in two independent cohorts.Results: We identified a nine-gene panel in the discovery phase, with subsequent validation in tissue specimens. Using a serum training cohort, we developed a 5-gene risk prediction formulae for the diagnosis of GC; bootstrapped analysis exhibited an AUC of 0.896. We validated this 5-gene biomarker panel using an independent serum cohort, yielding an AUC of 0.947. This biomarker panel successfully identified GC, regardless of tumour histology. Notably, biomarker performance for detection of stage 1 and 2 GC displayed an AUC of 0.928 and 0.980 in both serum cohorts.Conclusions: We identified a novel 5-gene biomarker panel for noninvasive diagnosis of GC, which might serve as a potential diagnostic tool for early detection. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
434. Clinical Discrimination of Chronic Pouchitis After Ileal Pouch-Anal Anastomosis in Patients with Ulcerative Colitis.
- Author
-
Okita, Yoshiki, Ohi, Masaki, Kitajima, Takahito, Shimura, Tadanobu, Yamamoto, Akira, Fujikawa, Hiroyuki, Okugawa, Yoshinaga, Matsushita, Kohei, Koike, Yuhki, Inoue, Mikihiro, Uchida, Keiichi, and Toiyama, Yuji
- Subjects
- *
ULCERATIVE colitis , *ANAL cancer , *INTESTINES , *MULTIVARIATE analysis - Abstract
Purpose: We aimed to identify predictive factors for the development of chronic pouchitis after ileal pouch-anal anastomosis in patients with ulcerative colitis. Methods: Three hundred eighty-seven patients who underwent ileal pouch-anal anastomosis for diagnosis of ulcerative colitis from January 2002 to March 2019 were included in this retrospective analysis. Results: Of 115 patients with pouchitis, 40 patients exhibited acute pouchitis, and 75 patients exhibited chronic pouchitis. Of 75 patients with chronic pouchitis, 11 patients were diagnosed with chronic antibiotic-refractory pouchitis. Multivariate analysis revealed that early pouchitis onset and modified Pouchitis Disease Activity Index score ≥ 7 were independent predictive factors for chronic pouchitis (p = 0.0004 and p = 0.029, respectively). Mean onset of pouchitis after intestinal continuity was significantly earlier in patients with chronic pouchitis than in patients with acute pouchitis (acute pouchitis vs. chronic pouchitis: 3.72 ± 2.98 years vs. 1.85 ± 2.40 years, p < 0.0001). Total modified Pouchitis Disease Activity Index score was significantly higher in patients with chronic pouchitis than in patients with acute pouchitis (acute pouchitis vs. chronic pouchitis: 5.9 ± 1.2 vs. 6.9 ± 1.6, p = 0.0020). Conclusion: Patients with ulcerative colitis were more likely to develop chronic pouchitis if they exhibited early onset or severe disease activity at onset. Evaluation of both factors can aid in early treatment decisions to alleviate chronic pouchitis. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
435. Preoperative heat shock protein 47 levels identify colorectal cancer patients with lymph node metastasis and poor prognosis.
- Author
-
Mori, Koichiro, Toiyama, Yuji, Okugawa, Yoshinaga, Ichikawa, Takashi, Nagano, Yuka, Oki, Satoshi, Shimura, Tadanobu, Fujikawa, Hiroyuki, Hiro, Junichiro, Kobayash, Minako, Araki, Toshimitsu, Inoue, Yasuhiro, Mohri, Yasuhiko, and Kusunoki, Masato
- Subjects
- *
LYMPHATIC metastasis , *HEAT shock proteins , *COLORECTAL cancer , *LYMPH node cancer , *BIOMARKERS , *CANCER invasiveness , *LUPUS nephritis , *COLECTOMY - Abstract
Accumulating evidence suggests that overexpression of heat shock protein 47 (HSP47) increases cancer progression, and that HSP47 level in the tumor-associated stroma may serve as a diagnostic marker in various cancers. The present study aimed to evaluate whether HSP47 gene expression in colorectal cancer (CRC) tissues could be used to identify lymph node (LN) metastasis status preoperatively in patients with CRC. To do so, HSP47 gene expression was determined and its association with the clinicopathological characteristics of patients with CRC was analyzed. A total of 139 surgical specimens from patients with CRC and 36 patients with benign colonic disease undergoing surgery at Mie University Hospital were analyzed. HSP47 gene expression was determined by reverse transcription quantitative PCR using Power SYBR Green PCR methods. Expression level of HSP47 was significantly higher in CRC tissues compared with normal tissue from patients with benign colonic disease. Furthermore, high HSP47 expression was significantly associated with tumor progression, including high T stage, lymph node metastasis and venous invasion, and high TNM stage. High HSP47 expression may therefore serve as a novel predictive biomarker for determining patients with CRC and LN metastasis. According to Kaplan-Meier analysis, patients with high HSP47 expression level had significantly poorer overall survival than those with low HSP47 expression level. Furthermore, multivariate analyses identified HSP47 expression as an independent predictive marker for LN metastasis and poor overall survival in patients with CRC. In summary, the present study demonstrated that HSP47 expression may be considered as a novel biomarker for predicting LN metastasis status and prognosis in patients with CRC. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
436. Billroth-I Reconstruction with Overlap Anastomosis Using an EndoWrist Linear Stapler After Robotic Distal Gastrectomy.
- Author
-
Ohi, Masaki, Toiyama, Yuji, Ichikawa, Takashi, Kitajima, Takahito, Imaoka, Hiroki, Yasuda, Hiromi, Okugawa, Yoshinaga, Fujikawa, Hiroyuki, Okita, Yoshiki, Yokoe, Takeshi, Hiro, Junichiro, and Kusunoki, Masato
- Subjects
- *
GASTRECTOMY , *SURGICAL complications , *STAPLERS (Surgery) , *ROBOTICS , *LAPAROSCOPIC surgery , *STOMACH cancer - Abstract
Introduction: Robotic distal gastrectomy (RDG) is now thought to be less invasive than conventional laparoscopic distal gastrectomy (LDG) for gastric cancer. Although the delta-shaped anastomosis is an established, widely performed procedure for intracorporeal Billroth-I (B-I) gastroduodenostomy after LDG, it has some difficulties and is performed in the ischemic region of the duodenum. We therefore developed a novel overlap B-I gastroduodenostomy after RDG. Materials and Methods: We started using the da Vinci Surgical System (Intuitive Surgical, Sunnyvale, CA) for RDG in May 2017. The robotic overlap B-I reconstruction was performed via side-to-side anastomosis, as follows: Two small incisions were made, one on the greater curvature of the remnant stomach, 5 cm from the edge of the remnant gastric stump, and one on the superior edge of the anterior wall of the duodenal stump. A 45-mm EndoWrist linear stapler device (EWLS) loaded with a blue cartridge was inserted through the incision. After the remnant stomach and duodenum were attached to the V-shaped form by the EWLS, the incisions were closed by the EWLS. Results: Seven patients underwent RDG followed by a robotic overlap B-I procedure up to March 2019. Short-term outcomes were determined from medical records and operative videos. No intraoperative complications or conversions to open or conventional laparoscopic surgery occurred. The mean time for the anastomosis was 37 (range 29-45 minutes) minutes. No postoperative complications occurred following the robotic overlap B-I procedure. Discussion: RDG followed by an overlap B-I gastroduodenostomy might be feasible and safe. However, long-term follow-up is required to identify additional benefits. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
437. Laparoscopic esophagogastrostomy using a knifeless linear stapler after proximal gastrectomy.
- Author
-
Ohi, Masaki, Toiyama, Yuji, Kitajima, Takahito, Shigemori, Tsunehiko, Yasuda, Hiromi, Okugawa, Yoshinaga, Fujikawa, Hiroyuki, Okita, Yoshiki, Yokoe, Takeshi, Hiro, Junichiro, Araki, Toshimitsu, and Kusunoki, Masato
- Subjects
- *
ESOPHAGOGASTRIC junction , *STOMACH cancer , *OPERATIVE surgery , *STAPLERS (Surgery) , *FUNDOPLICATION , *GASTRECTOMY - Abstract
Proximal gastrectomy should improve the late postoperative function in patients with gastric cancer located in the upper third of the stomach or esophagogastric junction. However, a standard method of esophagogastrostomy has not been established for improving the postoperative function. To prevent reflux and stenosis following proximal gastrectomy, we introduced a novel esophagogastrostomy method using a knifeless linear stapler. The stapler was inserted into holes created in both the esophagus and remnant stomach and fired proximally. A 1.5-cm incision was made from the edge of the entry hole between the staples. The entry hole was then closed with continuous sutures, and fundoplication was performed by wrapping the remnant stomach. We performed this technique in 12 consecutive patients without observing any anastomosis-related complications. The proportion of weight lost 1 year after surgery was 8.8%. Our surgical procedure might be feasible for treating gastric cancer located in the upper third of the stomach or esophagogastric junction. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
438. Identification of Predictors of Recurrence in Patients with Lower Rectal Cancer Undergoing Neoadjuvant Chemotherapy: A Direct Comparison of Short-Course and Long-Course Chemoradiotherapy.
- Author
-
Toiyama, Yuji, Yamamoto, Akira, Okugawa, Yoshinaga, Fujikawa, Hiroyuki, Hiro, Junichiro, Yasuda, Hiromi, Kobayashi, Minako, Ohi, Masaki, Araki, Toshimitsu, and Kusunoki, Masato
- Subjects
- *
RECTAL cancer treatment , *CANCER relapse , *ADJUVANT treatment of cancer , *CANCER chemotherapy , *TREATMENT duration - Published
- 2018
- Full Text
- View/download PDF
439. MO36-3 Clinical management of cancer of unknown primary with unfavorable subset: A retrospective analysis.
- Author
-
Tono, Yasutaka, Sukeno, Koushi, Tsunoda, Akira, Oka, Hiroki, Ishihara, Mikiya, Saito, Kanako, Tamaru, Satoshi, Yamashita, Yoshiki, Fujiwara, Takumi, Kitajima, Takahito, Okugawa, Yoshinaga, and Mizuno, Toshiro
- Subjects
- *
CANCER of unknown primary origin , *RETROSPECTIVE studies - Published
- 2023
- Full Text
- View/download PDF
440. Dysregulated DNA methylation in the pathogenesis of Fabry disease.
- Author
-
Shen, Jin-Song, Shigeyasu, Kunitoshi, Okugawa, Yoshinaga, Balaji, Uthra, Chan, Jinyan, Gu, Jinghua, Day, Taniqua, Jabbarzadeh-Tabrizi, Siamak, Schiffmann, Raphael, and Goel, Ajay
- Subjects
- *
DNA methylation , *ANGIOKERATOMA corporis diffusum , *ENDOTHELIAL cells , *TRANSCRIPTOMES , *ANDROGEN receptors - Published
- 2019
- Full Text
- View/download PDF
441. Possibility of limited gastrectomy for early gastric cancer located in the upper third of the stomach, based on the distribution of sentinel node basins.
- Author
-
Ohi, Masaki, Toiyama, Yuji, Omura, Yusuke, Ichikawa, Takashi, Yasuda, Hiromi, Okugawa, Yoshinaga, Fujikawa, Hiroyuki, Okita, Yoshiki, Yoshiyama, Shigeyuki, Hiro, Junichiro, Araki, Toshimitsu, and Kusunoki, Masato
- Subjects
- *
SENTINEL lymph nodes , *STOMACH cancer , *GASTRECTOMY , *STOMACH , *CANCER invasiveness - Abstract
Purpose: Several recent studies have evaluated the feasibility of the sentinel node (SN) concept for gastric cancer. The aim of our study was to investigate limited gastrectomy with SN basin dissection in SN navigation surgery (SNNS) for patients with early-gastric cancer located in the upper-third of the stomach. Methods: 147 patients received SNNS for early-gastric cancer at our institution. Of these, 26 patients diagnosed with early-gastric cancer < 4 cm in size and located in the upper-third of the stomach were retrospectively analyzed for the distribution of SN and SN basins. Results: In three of the 26 patients, lymph node metastasis was limited to the left gastric artery (LGA) basin. The breakdown of the basins were as follows: A single LGA basin, 19 cases; a non-single LGA basin, seven cases. A non-single LGA basin was significantly associated with the clinicopathological factors, such as tumor spread to the middle-third of the stomach, tumor location at the center of the greater curvature, and undifferentiated adenocarcinoma, compared to the single LGA basin group. Conclusions: Our data revealed that the distribution of the SN basins in early-gastric cancer measuring less than 4 cm in size and located in the upper-third of the stomach was significantly correlated with tumor spread, tumor location, and the pathological findings. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
442. Phase I study of preoperative chemoradiotherapy with sequential oxaliplatin and irinotecan with S-1 for locally advanced rectal cancer.
- Author
-
Fujikawa, Hiroyuki, Toiyama, Yuji, Inoue, Yasuhiro, Omura, Yusuke, Ide, Shozo, Kitajima, Takahito, Yasuda, Hiromi, Okugawa, Yoshinaga, Okita, Yoshiki, Yoshiyama, Shigeyuki, Hiro, Junichiro, Kobayashi, Minako, Ohi, Masaki, Araki, Toshimitsu, and Kusunoki, Masato
- Subjects
- *
RECTAL cancer , *OXALIPLATIN , *CHEMORADIOTHERAPY , *RADIATION doses - Abstract
The present study designed a novel preoperative chemoradiotherapy (CRT) with sequential oxaliplatin and irinotecan with S-1 for locally advanced rectal cancer (LARC). This phase I study evaluated the maximum tolerated dose and recommended dose (RD) of oxaliplatin following irinotecan with S-1. Patients with clinical stage T3 or 4 or involvement of the regional nodes and no evidence of distant metastases were treated with fixed doses of S-1 (80 mg/m2/day) on days 1–5, 8–12, 15–19, 22–27 and 29–33, and irinotecan (40 mg/m2/day) on days 1 and 8, followed by oxaliplatin on days 22 and 29. The dose of oxaliplatin was initially 40 mg/m2 (level 1) with a predefined dose escalation schedule. The radiation dose was 1.8 Gy/fraction to a total dose of 45 Gy. A total of 9 patients were enrolled in the present study and 7 patients completely received CRT with this study protocol. The maximum tolerated dose for oxaliplatin was 50 mg/m2 (level 2). Three of four patients experienced dose-limiting toxicity (grade 3 diarrhea) in oxaliplatin phase of level 2 dose. The RD of oxaliplatin was 40 mg/m2 (level 1 dose). In addition, 2 patients had pathological CR (28.5%). Novel preoperative CRT with sequential oxaliplatin and irinotecan with S-1 for LARC resulted in acceptable toxicity and promising efficacy. However, the RD of oxaliplatin was lower than in previous CRT studies that combined oxaliplatin with S-1. To administer higher oxaliplatin, we have planned a phase I trial of preoperative CRT with sequential oxaliplatin followed by irinotecan with S-1 for LARC. [ABSTRACT FROM AUTHOR]
- Published
- 2019
443. Risk factors and measures of pulmonary complications after thoracoscopic esophagectomy for esophageal cancer.
- Author
-
Ohi, Masaki, Toiyama, Yuji, Omura, Yusuke, Ichikawa, Takashi, Yasuda, Hiromi, Okugawa, Yoshinaga, Fujikawa, Hiroyuki, Okita, Yoshiki, Yoshiyama, Shigeyuki, Hiro, Junichiro, Araki, Toshimitsu, and Kusunoki, Masato
- Subjects
- *
ESOPHAGEAL cancer , *DELIRIUM , *ESOPHAGECTOMY , *SURGICAL complications , *OBSTRUCTIVE lung diseases - Abstract
Purpose: Postoperative pulmonary complications (PCs) after thoracoscopic esophagectomy for esophageal cancer (EC) still occur too frequently. We conducted this study to identify the risk factors for PCs developing in EC patients who undergo thoracoscopic esophagectomy.Methods: The subjects of this retrospective study were 89 patients with EC who underwent thoracoscopic esophagectomy in our department between January 2010 and December 2015. Univariate and multivariate logistic regression analyses were used to evaluate the association between the incidence of PC and clinical factors. In January 2016, we introduced a new prophylactic intervention for reducing the incidence of delirium and assessed its significance for PCs.Results: PCs developed in 19 patients (21.3%). Univariate analysis revealed the following risk factors: age (> 69 years), ratio of the forced expiratory volume in 1 s to forced vital capacity (< 70%), chronic obstructive pulmonary disease (COPD), and postoperative delirium. Multivariate analysis found that COPD and postoperative delirium were independent risk factors for PCs. Our new intervention for delirium significantly reduced its occurrence (p = 0.00004) and also the frequency of PCs (p = 0.04148).Conclusions: Postoperative delirium and COPD were risk factors for PCs in patients who underwent thoracoscopic esophagectomy. Our intervention study showed clearly that reducing the occurrence of postoperative delirium could decrease the incidence of PCs. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
444. Downregulation of trefoil factor‑3 expression in the rectum is associated with the development of ulcerative colitis‑associated cancer.
- Author
-
Kondo, Satoru, Araki, Toshimitsu, Toiyama, Yuji, Tanaka, Koji, Kawamura, Mikio, Okugawa, Yoshinaga, Okita, Yoshiki, Saigusa, Susumu, Inoue, Yasuhiro, Uchida, Keiichi, Mohri, Yasuhiko, and Kusunoki, Masato
- Subjects
- *
RECTAL cancer diagnosis , *RECTAL cancer , *ULCERATIVE colitis , *DOWNREGULATION , *TREFOIL factors , *GENE expression , *GENETICS , *THERAPEUTICS - Abstract
Diagnostic markers facilitate more selective screening and treatment strategies for ulcerative colitis (UC)‑associated cancer (UCAC). The expression of trefoil factor‑3 (TFF3), which is involved in mucosal protection and repair in the gastrointestinal tract, was analyzed and its significance for UCAC was evaluated. A total of 145 patients with UC who underwent proctocolectomies were enrolled, including 15 patients (10.8%) with UCAC. TFF3 expression in the rectal mucosa and in cancer cells was assessed using immunohistochemistry, and the expression in UCAC and sporadic colorectal cancer was compared. Analyzing the mucinous granules of goblet cells located in crypts revealed that the non‑cancerous rectal mucosa of patients with UCAC had significantly lower mean TFF3 staining scores compared with patients with UC without UCAC or patients with sporadic cancer. TFF3 staining score was revealed to be an independent predictor of UCAC development. These results indicated that low TFF3 expression in the rectal mucosa was associated with the development of UCAC. Thus, TFF3 expression in the rectal mucosa may be a useful biomarker for monitoring patients with UC. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
445. Cardiac 18F‑FDG uptake and new‑onset rectal cancer.
- Author
-
Sawaragi, Kazuhito, Okada, Yukinori, Aono, Yuuki, Yasuoka, Ryo, Takayama, Shoji, Yao, Ryuuji, Mitsuyama, Toshiyuki, Saigusa, Susumu, Fujikawa, Hiroyuki, Mori, Tomomi, Hashimoto, Manabu, Higashi, Koki, Sakurai, Hiroyuki, Tanaka, Koji, Okugawa, Yoshinaga, Tanaka, Naoshi, Toiyama, Yuji, Okazaki, Kazuichi, and Naganuma, Makoto
- Subjects
- *
POSITRON emission tomography computed tomography , *POSITRON emission tomography , *FLUORODEOXYGLUCOSE F18 , *RECTAL cancer , *COLON cancer , *RECEIVER operating characteristic curves - Abstract
The present study aimed to investigate the factors affecting the cardiac uptake of 18F-fluorodeoxyglucose (18F-FDG) during 18F-FDG positron emission tomography (PET) for new-onset rectal cancer and new-onset colon cancer (ascending, transverse, descending, sigmoid colon cancer) and to examine the association between the cardiac uptake of 18F-FDG and prognosis. The participants were diagnosed with new-onset rectal cancer and new-onset colon cancer (ascending, transverse, descending, sigmoid cancer) at the Iga City General Hospital (Iga, Japan) between January 1, 2013, and March 31, 2018, and underwent an 18F-FDG PET scan for pretreatment staging. The relationship between cardiac maximum standard uptake value (SUVmax), the presence/absence of distant metastasis and prognosis was examined. A total of 26 patients (14 men and 12 women) aged 72.0±10 years with new-onset rectal cancer were selected for the study. No patients had multiple simultaneous cancers. The median cardiac SUVmax was 3.8 and 2.5 in patients with no distant metastasis and distant metastasis, respectively, revealing a statistically significant difference (P<0.01). The median tumor volume on PET-computed tomography (CT) images was 7,815 cm2 and was 66,248 cm2 in patients with no distant metastasis and distant metastasis, respectively, revealing a statistically significant difference (P<0.01). Echocardiography findings revealed no significant difference between patients with and without distant metastasis. The correlation coefficient between cardiac SUVmax and total tumor volume on PET/CT images (primary + lymph + distant metastases) was statistically significant (r=−0.42, P=0.03). Analysis of the association between the occurrence of distance metastasis and cardiac SUVmax as a continuous variable gave a statistically significant result [hazard ratio (HR): 0.30, 95% confidence interval (CI): 0.09-0.98, P=0.045]. Receiver operating characteristic analysis showed a cardiac SUVmax of 2.6 with an area under the curve of 0.86 for determining the presence of distant metastasis (95% CI: 0.70-1.00). The median observation time was 56 months, and nine patients died during observation. Analysis of the association between the overall survival and cardiac SUVmax (cutoff: 2.6) showed 95% CI: 0.01-0.45 and HR: 0.06 (P<0.01); that between the overall survival and total tumor volume on PET images showed 95% CI: 1.00-1.00 and HR: 1.00 (P<0.01); and that between the overall survival and presence of distant metastasis showed 95% CI: 1.72-116.4 and HR: 14.1 (P<0.01). Furthermore, 25 patients (16 men and nine women) aged 71.4±14.2 years with new-onset colon cancer were selected for the study. Analysis of new-onset colon cancer revealed no statistically significance between the cardiac SUVmax and distant metastasis. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
446. Exacerbation of Dermatomyositis with Recurrence of Rectal Cancer: A Case Report.
- Author
-
Nagano, Yuka, Inoue, Yasuhiro, Shimura, Tadanobu, Fujikawa, Hiroyuki, Okugawa, Yoshinaga, Hiro, Junichiro, Toiyama, Yuji, Tanaka, Koji, Mohri, Yasuhiko, and Kusunoki, Masato
- Abstract
Dermatomyositis (DM) is a rare idiopathic inflammatory myopathy characterized by cutaneous and muscle manifestations. The association between DM and malignancy has been well recognized for many years. The clinical course of paraneoplastic DM may be affected by malignancies, although the cause and effect relationship between exacerbation of DM and cancer progression is uncertain. Herein, we report a 44-year-old woman who presented with progressive DM associated with rectal cancer. After curative resection of rectal cancer, DM symptoms resolved. Three months after surgery, blood test surveillance showed elevation of serum carcinoembryonic antigen levels, although the patient remained asymptomatic. One month later she had a DM flare-up, and multiple lung and liver metastases were found. She immediately underwent cancer chemotherapy with prednisolone therapy for DM. However, her condition deteriorated and she was unable to swallow. Percutaneous endoscopic gastrostomy was constructed, allowing alimentation and oral delivery, which made it possible to keep her on chemotherapy. She had remarkable response for unresectable metastases 8 weeks after the administration of chemotherapy. Seven months after onset of recurrence, her condition improved considerably and she had stable disease. Moreover, she can now eat food of soft consistency. Our case provides further support for the clinical importance of cancer chemotherapy for patients who have progressive DM and unresectable rectal cancer. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
447. Immunodeficiency and Autoimmune Enterocolopathy Linked to NFAT5 Haploinsufficiency.
- Author
-
Boland, Brigid S., Widjaja, Christella E., Banno, Asoka, Zhang, Bing, Kim, Stephanie H., Stoven, Samantha, Peterson, Michael R., Jones, Marilyn C., Su, H. Irene, Crowe, Sheila E., Bui, Jack D., Ho, Samuel B., Okugawa, Yoshinaga, Goel, Ajay, Marietta, Eric V., Khosroheidari, Mahdieh, Jepsen, Kristen, Aramburu, Jose, López-Rodríguez, Cristina, and Sandborn, William J.
- Subjects
- *
AUTOIMMUNE diseases , *IMMUNOLOGICAL deficiency syndromes , *CELL proliferation , *T cells , *TRANSCRIPTION factors , *IMMUNODEFICIENCY - Abstract
The link between autoimmune diseases and primary immunodeficiency syndromes has been increasingly appreciated. Immunologic evaluation of a young man with autoimmune enterocolopathy and unexplained infections revealed evidence of immunodeficiency, including IgG subclass deficiency, impaired Ag-induced lymphocyte proliferation, reduced cytokine production by CD8+ T lymphocytes, and decreased numbers of NK cells. Genetic evaluation identified haploinsufficiency of NFAT5, a transcription factor regulating immune cell function and cellular adaptation to hyperosmotic stress, as a possible cause of this syndrome. Inhibition or deletion of NFAT5 in normal human and murine cells recapitulated several of the immune deficits identified in the patient. These results provide evidence of a primary immunodeficiency disorder associated with organ-specific autoimmunity linked to NFAT5 deficiency. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
448. RacGAP1 expression, increasing tumor malignant potential, as a predictive biomarker for lymph node metastasis and poor prognosis in colorectal cancer.
- Author
-
Imaoka, Hiroki, Toiyama, Yuji, Saigusa, Susumu, Kawamura, Mikio, Kawamoto, Aya, Okugawa, Yoshinaga, Hiro, Junichiro, Tanaka, Koji, Inoue, Yasuhiro, Mohri, Yasuhiko, and Kusunoki, Masato
- Subjects
- *
GTPASE-activating protein , *GENE expression , *BIOMARKERS , *LYMPH node physiology , *METASTASIS , *COLON cancer prognosis , *CANCER invasiveness - Abstract
We for the first time demonstrated that high expression of tissue RacGAP1 was associated with tumor progression and metastasis and could serve as a promising biomarker for the prediction of lymph node metastasis and poor prognosis in CRC patients.Rac GTPase-activating protein (RacGAP) 1 plays a key role in controlling various cellular phenomena including cytokinesis, transformation, invasive migration and metastasis. This study investigated the function and clinical significance of RacGAP1 expression in colorectal cancer (CRC). The intrinsic functions of RacGAP1 in CRC cells were analyzed using small interfering RNA (siRNA). We analyzed RacGAP1 mRNA expression in surgical specimens from 193 CRC patients (Cohort 1) by real-time PCR. Finally, we validated RacGAP1 protein expression using formalin-fixed paraffin-embedded samples from 298 CRC patients (Cohort 2) by immunohistochemistry. Reduced RacGAP1 expression by siRNA in CRC cell lines showed significantly decreased cellular proliferation, migration and invasion. In Cohort 1, RacGAP1 expression in CRC was significantly higher than in adjacent normal mucosa and increased according to tumor node metastasis stage progression. High RacGAP1 expression in tumors was significantly associated with progression and prognosis. In Cohort 2, RacGAP1 protein was overexpressed mainly in the nuclei of CRC cells; however, its expression was scarcely observed in normal colorectal mucosa. RacGAP1 protein expression was significantly higher in CRC patients with higher T stage, vessel invasion and lymph node and distant metastasis. Increased expression of RacGAP1 protein was significantly associated with poor disease-free and overall survival. Multivariate analyses revealed that high RacGAP1 expression was an independent predictive marker for lymph node metastasis, recurrence and poor prognosis in CRC. Our data provide novel evidence for the biological and clinical significance of RacGAP1 as a potential biomarker for identifying patients with lymph node metastasis and poor prognosis in CRC. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
449. In Vivo Characterization of Neutrophil Extracellular Traps in Various Organs of a Murine Sepsis Model.
- Author
-
Tanaka, Koji, Koike, Yuhki, Shimura, Tadanobu, Okigami, Masato, Ide, Shozo, Toiyama, Yuji, Okugawa, Yoshinaga, Inoue, Yasuhiro, Araki, Toshimitsu, Uchida, Keiichi, Mohri, Yasuhiko, Mizoguchi, Akira, and Kusunoki, Masato
- Subjects
- *
NEUTROPHILS , *EXTRACELLULAR matrix , *SEPSIS , *AUTOIMMUNE diseases , *CANCER invasiveness , *BLOOD platelets - Abstract
Neutrophil extracellular traps (NETs) represent extracellular microbial trapping and killing. Recently, it has been implicated in thrombogenesis, autoimmune disease, and cancer progression. The aim of this study was to characterize NETs in various organs of a murine sepsis model in vivo and to investigate their associations with platelets, leukocytes, or vascular endothelium. NETs were classified as two distinct forms; cell-free NETs that were released away from neutrophils and anchored NETs that were anchored to neutrophils. Circulating cell-free NETs were characterized as fragmented or cotton-like structures, while anchored NETs were characterized as linear, reticular, membranous, or spot-like structures. In septic mice, both anchored and cell-free NETs were significantly increased in postcapillary venules of the cecum and hepatic sinusoids with increased leukocyte-endothelial interactions. NETs were also observed in both alveolar space and pulmonary capillaries of the lung. The interactions of NETs with platelet aggregates, leukocyte-platelet aggregates or vascular endothelium of arterioles and venules were observed in the microcirculation of septic mice. Microvessel occlusions which may be caused by platelet aggregates or leukocyte-platelet aggregates and heterogeneously decreased blood flow were also observed in septic mice. NETs appeared to be associated with the formation of platelet aggregates or leukocyte-platelet aggregates. These observational findings may suggest the adverse effect of intravascular NETs on the host during a sepsis. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
450. Molecular characteristics of residual cancer and stromal cells after chemoradiotherapy for gastric cancer: report of four cases.
- Author
-
Tanaka, Koji, Mohri, Yasuhiko, Koike, Yuhki, Okugawa, Yoshinaga, Toiyama, Yuji, Ohi, Masaki, Kobayashi, Minako, Inoue, Yasuhiro, Araki, Toshimitsu, Uchida, Keiichi, Miki, Chikao, and Kusunoki, Masato
- Subjects
- *
GASTROINTESTINAL cancer , *RADIOTHERAPY , *FLUOROURACIL , *CISPLATIN , *CANCER chemotherapy , *REVERSE transcriptase polymerase chain reaction - Abstract
Key Clinical Message Four patients with gastric cancer underwent 5-fluorouracil and cisplatin-based chemoradiotherapy followed by surgery. Expression analysis of chemoradiosensitivity related genes in residual cancer using formalin-fixed paraffin-embedded specimens may be useful when determining a chemotherapy regimen for disease recurrence after chemoradiotherapy for gastric cancer. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.